Pancreatic Cancer Symptoms & When Surgery Is Possible

Need expert consultation? Book an appointment with Dr. Babu Elangovan.
Book AppointmentPancreatic cancer is often quiet until it presses on a duct or nerve. That is why families search for pancreatic cancer symptoms and, soon after, ask the harder question: when is surgery possible? This guide explains the symptoms that should prompt a scan, and then the four words a surgical team uses when reading that scan: resectable, borderline, locally advanced, and metastatic.
What recovery looks like after pancreatic head resection is covered in understanding the Whipple procedure and recovery. If jaundice is the presenting problem and cancer has not been confirmed, what causes jaundice in adults runs through the other causes.
Dr. Babu Elangovan is a Surgical Gastroenterologist in Chennai whose practice centres on HPB surgery and GI cancer surgery. With 20+ years of liver and pancreatic operative work, he helps patients interpret scans and choose the safest next step.
Why Symptoms Often Appear Late
The pancreas sits deep in the upper abdomen. Small tumours in the body or tail can grow without blocking the bile duct. Tumours in the head of the pancreas more often cause jaundice earlier because they compress the common bile duct.
By the time symptoms push someone to a scan, the question is no longer only “what is wrong?” but “can this be removed completely?” Only a minority of patients present with clearly resectable disease, which is why prompt specialist staging matters.
Pancreatic Cancer Symptoms Worth Taking Seriously
No single symptom proves cancer. Clusters and persistence matter more than one day of discomfort.
Jaundice-related clues (especially painless)
- Yellowing of eyes or skin
- Dark urine
- Pale or clay-coloured stools
- Itching (pruritus)
Painless progressive jaundice in an adult is a classic reason to image the pancreas and bile ducts urgently.
Pain and digestion
- Upper-abdominal pain that may radiate to the back
- Early fullness, nausea, or indigestion that does not settle
- Unexplained weight loss and loss of appetite
- Oily, floating stools (fat maldigestion) in some cases
Metabolic and vascular clues
- New-onset diabetes or sudden worsening of existing diabetes
- Unexplained blood clots in some patients
- Fatigue from obstruction, poor intake, or advanced disease
Symptoms overlap with gallstone disease, chronic pancreatitis, and peptic disorders. That overlap is why self-diagnosis is unsafe, and why a pancreatic-protocol scan plus specialist review beats waiting for “one more week of home remedies.”
If bile-duct stones are the cause instead of a tumour, the pathway is different. See bile duct stones: symptoms and treatment. Imaging distinguishes the two.
How Teams Confirm Diagnosis and Stage Disease
A typical work-up may include:
- Blood tests: liver function, blood counts, and tumour marker CA 19-9 as an adjunct (not a solo diagnostic test)
- Contrast CT and/or MRI/MRCP: maps the tumour and its relationship to mesenteric vessels
- Endoscopic ultrasound (EUS): can sample tissue when needed
- ERCP: mainly therapeutic when jaundice needs stenting; tissue sampling may be possible in selected settings
- Staging for metastases: looking for spread to liver, peritoneum, or distant sites
Treatment planning for pancreatic cancer is ideally multidisciplinary. Anatomy, biology (including CA 19-9 trends), and the patient’s fitness all influence whether surgery comes first.
When Surgery Is Possible: Resectability in Plain English
Surgery aims for complete removal with clear margins (R0 resection) when there is no distant spread and the patient can tolerate a major operation. Indian consensus documents and international criteria group non-metastatic disease roughly as follows:
| Category | Plain meaning | Usual first direction |
|---|---|---|
| Resectable | Tumour appears removable without major vessel problems that would leave cancer behind | Upfront surgery often considered, followed by adjuvant therapy as advised |
| Borderline resectable | Limited vessel involvement; higher risk of positive margins if operated immediately | Neoadjuvant chemotherapy (± radiotherapy in selected protocols), then restaging |
| Locally advanced | Extensive arterial encasement or vessel involvement that makes safe complete resection unlikely | Systemic therapy first; surgery only if major downstaging occurs |
| Metastatic | Spread beyond the pancreas to distant sites | Systemic therapy and symptom control; surgery is not curative in this setting |
These labels come from imaging and specialist review, not from how severe the pain feels.
What “surgery is possible” requires
- No convincing distant metastases on quality staging
- Anatomy that allows complete removal (or potential conversion after neoadjuvant therapy in borderline cases)
- Performance status and nutrition adequate for major HPB surgery
- A plan for perioperative care, including diabetes and nutrition support
Age alone is not an automatic veto at experienced centres, but severe frailty or uncontrolled comorbidity can make non-operative strategies safer.
Borderline Resectable Disease: Why Chemotherapy May Come First
Borderline tumours often touch or narrow veins such as the portal vein / SMV, or abut arteries over a limited circumference. Upfront surgery can leave microscopic disease at the edge. Neoadjuvant therapy aims to:
- Treat micrometastases earlier
- Improve the chance of a clear margin
- Identify patients whose disease progresses quickly and would not have benefited from immediate major surgery
After therapy, scans and tumour markers are repeated. Stable or responding disease may proceed to surgical exploration and resection, sometimes with venous reconstruction. Extensive arterial resection is generally avoided because risk is high and benefit uncertain for most patients.
Operations Used When Surgery Goes Ahead
Whipple procedure (pancreaticoduodenectomy)
For many head-of-pancreas tumours, the Whipple procedure in Chennai removes the pancreatic head, duodenum, gallbladder, and bile duct segment, with reconstruction of digestive and biliary drainage. It is a major operation that needs experienced HPB teams and careful recovery planning.
Distal pancreatectomy
Body and tail tumours may be removed with the left side of the pancreas, sometimes including the spleen, when oncologically required.
Vascular resection
Selected vein reconstructions can be part of a curative-intent operation in specialised hands. This is decided intraoperatively and on pre-operative vessel mapping, not promised from a blog checklist.
Why a second surgical opinion helps
Scan reports sometimes say “unresectable” when a high-volume HPB surgeon would still consider borderline pathways, or the reverse: an optimistic note that ignores arterial encasement. Bring DICOM images if possible. A careful vessel-by-vessel read changes counselling more than another blood test alone.
When Surgery Is Not the First (or Any) Curative Step
Metastatic disease and many locally advanced tumours are treated primarily with systemic therapy. That does not mean “nothing can be done.” Supportive procedures matter:
- Biliary stenting via ERCP to relieve jaundice and enable chemotherapy
- Pain control and nutrition support
- Palliative surgical bypass in selected obstruction scenarios when endoscopy is insufficient
Recovery after stenting and what to watch for are covered in ERCP recovery: diet, side effects and warning signs.
Eating after major pancreatic resection has its own guidance in eating well after pancreatic surgery.
If a scan report has left your family uncertain whether a tumour is “operable,” bring the images, not only the paper summary, for a surgical HPB review. Book an appointment with Dr. Babu Elangovan at his Chennai locations.
Practical Next Steps If You Have Warning Symptoms

- Do not ignore progressive jaundice or rapid weight loss with upper-abdominal pain
- Ask for quality pancreatic-protocol imaging rather than a vague abdominal ultrasound alone when suspicion is high
- Seek an HPB / GI cancer surgical opinion early. Resectability windows can close
- Keep a folder of labs, CA 19-9 trends, and prior endoscopy reports
- Discuss clinical trial or neoadjuvant pathways when borderline anatomy is reported
Care With Dr. Babu Elangovan in Chennai
Pancreatic cancer decisions are time-sensitive and technical. Dr. Babu Elangovan provides continuity from assessment through operative care where surgery is appropriate, working within Chennai centres such as Kauvery Alwarpet and Mira Health Care Adyar. Outstation families can request a remote second opinion on imaging before travel.
For a personalised review of symptoms or resectability, request a consultation or call +91 99626 60009.
References
- Indian Council of Medical Research (ICMR). Consensus document for the management of pancreatic cancer.
- Indian consensus / IJMPO guidance. Contemporary Indian perspectives on resectability, neoadjuvant therapy, and multidisciplinary care.
- NCCN / IAP frameworks (international reference). Anatomical definitions of resectable and borderline resectable pancreatic adenocarcinoma.
- EASL / oncology society guidance. Supportive principles for jaundice management and staging before HPB resection.
Authored by



